siRNA nanoparticles: the future of RNAi therapeutics for oncology? - Wikidata - awgldk - TriplyDB

siRNA nanoparticles: the future of RNAi therapeutics for oncology?

siRNA nanoparticles: the future of RNAi therapeutics for oncology?

http://www.wikidata.org/entity/Q38938368

about

Advanced Strategies in Immune Modulation of Cancer Using Lipid-Based Nanoparticles.Variable Heavy Chain Domain Derived from a Cell-Penetrating Anti-DNA Monoclonal Antibody for the Intracellular Delivery of Biomolecules.

P2860

Q37625459-98FF6ACB-F0A7-4D7C-909B-1B50F6F134CC Q50743140-F9722FB6-3C5A-402E-98DA-D69630BE41FD

P2860

siRNA nanoparticles: the future of RNAi therapeutics for oncology?

http://www.wikidata.org/entity/Q38938368

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

siRNA nanoparticles: the future of RNAi therapeutics for oncology?

@en

type

label

siRNA nanoparticles: the future of RNAi therapeutics for oncology?

@en

prefLabel

siRNA nanoparticles: the future of RNAi therapeutics for oncology?

@en

P1433

Q38938368-51D68AF6-B0CE-447F-8FB0-16F3475A62D0

P1476

Q38938368-AE33A085-1036-45B9-8F54-62C8710A328D

P2093

Q38938368-171CD02F-F93B-4E8B-B3EC-97D53B221BB0

Q38938368-AB5453E9-DEA8-418B-B27C-BA9B4047801A

P2860

Q38938368-0207CA4A-CF00-498F-8DB7-5EBD484C6734

Q38938368-0E9F4E29-47BC-4DC2-B421-BBF4E475B2A5

Q38938368-14941A81-5CED-491B-B4B1-E2DDA8B07FFD

Q38938368-26968975-0E7F-4E36-8C20-59537F6C7337

Q38938368-37DB005D-2066-409A-A068-C9E9FC69C25E

Q38938368-3C2AB67F-354E-4BE4-8472-47B89165C476

Q38938368-40980BC5-BF90-4428-9A05-4BB115FA49B5

Q38938368-41883E87-6FB2-4950-B2F1-787AF74F1E2F

Q38938368-435A15DF-378A-40C5-9E5A-0C5121FB83FD

Q38938368-472FFCF0-F103-47AD-A37B-817E52621221

P304

Q38938368-790FC368-B8D9-49E2-BA92-AA4B5096A350

P31

Q38938368-3784a545-e125-4777-8802-3dfbeae3a057

Q38938368-A46AF1D0-E1CF-457D-8D34-130E469278D9

P356

Q38938368-1265F598-D835-4957-9F95-8ED8F23C7835

P433

Q38938368-E32409B4-FEC5-4139-9E19-AEB07E8CA0FB

P478

Q38938368-B7D9F7D8-71F8-42C1-982A-ACAB1DB91E46

P577

Q38938368-A5E916CB-6E20-4B4C-84C9-991BC27E98E0

P5875

Q38938368-E9E1BFA1-8A57-48D2-A99D-1518CCA4041C

P698

Q38938368-13658F70-E7B0-4254-B7AC-C5BA299A4ECA

P921

Q38938368-DD366FF8-77B0-4919-8540-A0BA40932966

P932

Q38938368-876555C1-98B4-449C-8449-90BBD3E23949

P356

P1433

P1476

siRNA nanoparticles: the future of RNAi therapeutics for oncology?

@en

P2093

A James Mixson

http://www.w3.org/2001/XMLSchema#string

Szu-Ting Chou

http://www.w3.org/2001/XMLSchema#string

P2860

Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging

Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles

Lipid-like materials for low-dose, in vivo gene silencing

Cell-type-specific, Aptamer-functionalized Agents for Targeted Disease Therapy

Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs.

Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivo.

SNS01-T modulation of eIF5A inhibits B-cell cancer progression and synergizes with bortezomib and lenalidomide.

Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy.

Surface-modified HK:siRNA nanoplexes with enhanced pharmacokinetics and tumor growth inhibition.

Enhancing tumor cell response to chemotherapy through nanoparticle-mediated codelivery of siRNA and cisplatin prodrug.

P304

2251-2254

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/NNM.14.157

http://www.w3.org/2001/XMLSchema#string

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268796302

http://www.w3.org/2001/XMLSchema#string

P698

25413851

http://www.w3.org/2001/XMLSchema#string

P921

P932

4788000

http://www.w3.org/2001/XMLSchema#string